AU Patent

AU2011226911B2 — Management of breakthrough bleeding in extended hormonal contraceptive regimens

Assigned to Bayer Intellectual Property GmbH · Expires 2014-06-19 · 12y expired

What this patent protects

MANAGEMENT OF BREAKTHROUGH BLEEDING IN EXTENDED HORMONAL CONTRACEPTIVE REGIMENS Abstract The present invention relates to a flexible extended use regimen for a hormonal 5 contraceptive useful to manage bleeding problems associated with fixed extended use of hormonal contraceptive…

USPTO Abstract

MANAGEMENT OF BREAKTHROUGH BLEEDING IN EXTENDED HORMONAL CONTRACEPTIVE REGIMENS Abstract The present invention relates to a flexible extended use regimen for a hormonal 5 contraceptive useful to manage bleeding problems associated with fixed extended use of hormonal contraceptives and to a pharmaceutical package containing the respective hormonal contraceptive.

Drugs covered by this patent

Patent Metadata

Patent number
AU2011226911B2
Jurisdiction
AU
Classification
—
Expires
2014-06-19
Drug substance claim
No
Drug product claim
No
Assignee
Bayer Intellectual Property GmbH
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.